GGrantIndex
← Leaderboards

Shukti Chakravarti

New York University School Of Medicine

$13,351,356
Attributed
$13,351,356
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,351,356 · 8

By mechanism

R01$11,496,103 · 3
R21$909,497 · 2
R56$474,342 · 1
P01$441,414 · 1
R13$30,000 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Extracellular Matrix

Research focus

Extracellular MatrixCorneaCellsResponseProteoglycanMediatingSignal TransductionCytokineCollagenProteinsAffectLeadMolecularCell Culture TechniquesVariantRecombinantsKeratitisVisionInflammationInflammatoryLumicanRegulationBlindnessInfection

Grant awards (44)

Cellular and Genetic Defects in Keratoconus$618,407
R01 · FY2025 · EY · contact PI
Cellular and Genetic Defects in Keratoconus$615,948
R01 · FY2024 · EY · contact PI
Cellular and Genetic Defects in Keratoconus$625,118
R01 · FY2023 · EY · contact PI
Extracellular matrix proteoglycans regulate toll-like receptors 4 and 9$410,000
R01 · FY2023 · EY · contact PI
Extracellular matrix proteoglycans regulate toll-like receptors 4 and 9 - Equipment Supplement$45,201
R01 · FY2023 · EY · contact PI
Extracellular matrix proteoglycans regulate toll-like receptors 4 and 9$397,700
R01 · FY2022 · EY · contact PI
The role of NBEAL2 in the cornea$246,622
R21 · FY2022 · EY · contact PI
Extracellular matrix proteoglycans regulate toll-like receptors 4 and 9$397,700
R01 · FY2021 · EY · contact PI
The role of NBEAL2 in the cornea$211,875
R21 · FY2021 · EY · contact PI
Extracellular matrix proteoglycans regulate toll-like receptors 4 and 9$410,000
R01 · FY2020 · EY · contact PI
Extracellular matrix proteoglycans regulate toll-like receptors 4 and 9$100,252
R01 · FY2020 · EY · contact PI
TGF beta and AKT signal-driven pathogenesis in keratoconus$606,483
R01 · FY2018 · EY · contact PI
TGF beta and AKT signal-driven pathogenesis in keratoconus$579,647
R01 · FY2017 · EY · contact PI
The Role of Lumican in the Cornea$360,467
R01 · FY2017 · EY · contact PI
Role of Lumican in eye development and functions of the cornea$44,533
R01 · FY2017 · EY · contact PI
TGF beta and AKT signal-driven pathogenesis in keratoconus$579,647
R01 · FY2016 · EY · contact PI
The Role of Lumican in the Cornea$405,000
R01 · FY2016 · EY · contact PI
The Role of Lumican in the Cornea$40,054
R01 · FY2016 · EY · contact PI
The Role of Lumican in the Cornea$396,900
R01 · FY2015 · EY · contact PI
The Role of Lumican in the Cornea$405,000
R01 · FY2014 · EY · contact PI
The Role of Lumican in the Cornea$47,609
R01 · FY2014 · EY · contact PI
The Role of Lumican in the cornea$389,664
R01 · FY2012 · EY · contact PI
Functions of mammalian PGLYRPs in the cornea$205,000
R21 · FY2012 · EY · contact PI
The Role of Lumican in the cornea$389,664
R01 · FY2011 · EY · contact PI
Functions of mammalian PGLYRPs in the cornea$246,000
R21 · FY2011 · EY · contact PI
The Role of Lumican in the cornea$405,900
R01 · FY2010 · EY · contact PI
2010 Biology and Pathobiology of The Cornea$30,000
R13 · FY2010 · EY · contact PI
The Role of Lumican in the cornea$410,000
R01 · FY2009 · EY · contact PI
The Role of Lumican in the cornea$263,920
R01 · FY2009 · EY · contact PI
The Role of Lumican in the cornea$410,000
R01 · FY2008 · EY · contact PI
The Role of Lumican in the cornea$474,342
R56 · FY2007 · EY · contact PI
Role of Lumican in the Cornea$319,316
R01 · FY2006 · EY · contact PI
Role of Lumican in the Cornea$327,000
R01 · FY2005 · EY
Role of Lumican in the Cornea$6,031
R01 · FY2005 · EY
Role of Lumican in the Cornea$327,000
R01 · FY2004 · EY
Role of Lumican in the Cornea$327,000
R01 · FY2003 · EY
Role of Lumican in the Cornea$82,796
R01 · FY2003 · EY
Role of Lumican in the Cornea$327,000
R01 · FY2002 · EY
Extracellular matrix in pediatric IBD$147,138
P01 · FY2002 · DK
LUMICAN AND EYE DEVELOPMENT AND FUNCTIONS$222,925
R01 · FY2001 · EY
Extracellular matrix in pediatric IBD$147,138
P01 · FY2001 · DK
Extracellular matrix in pediatric IBD$147,138
P01 · FY2000 · DK
LUMICAN AND EYE DEVELOPMENT AND FUNCTIONS$103,754
R01 · FY2000 · EY
LUMICAN AND EYE DEVELOPMENT AND FUNCTIONS$98,467
R01 · FY2000 · EY